The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study
Open accessAbstract
OBJECTIVE: To investigate the duration of the presence of maternal antibodies to measles in infants. DESIGN: Prospective study (May 2006 to November 2008). SETTING: Five hospitals in the Province of Antwerp, Belgium. PARTICIPANTS: Of 221 pregnant women recruited, 207 healthy woman-infant pairs were included-divided into a vaccinated group (n=87) and naturally immune group (n=120), according to vaccination documents and history. MAIN OUTCOME MEASURE: Measles IgG antibodies measured by enzyme linked immunosorbent assay (ELISA) at seven time points (week 36 of pregnancy, birth (cord), and 1, 6, 9, and 12 months); decay of maternal antibody in infants modelled with linear mixed models. RESULTS: Vaccinated women had significantly fewer IgG antibodies (geometric mean titre 779 (95% confidence interval 581 to 1045) mIU/ml) than did naturally immune women (2687 (2126 to 3373) mIU/ml) (P<0.001). Maternal values were highly correlated with neonatal values (r=0.93 at birth). Infants of vaccinated women had significantly lower antibody concentrations than did infants of naturally immune women (P<0.001 at all ages over the follow-up period). Presence of maternal antibodies endured for a median of 2.61 months-3.78 months for infants of naturally infected women and 0.97 months for infants of vaccinated women. At 6 months of age, more than 99% of infants of vaccinated women and 95% of infants of naturally immune women had lost maternal antibodies according to the model. CONCLUSIONS: This study describes a very early susceptibility to measles in infants of both vaccinated women and women with naturally acquired immunity. This finding is important in view of recent outbreaks and is an argument for timeliness of the first dose of a measles vaccine and vaccination of travelling or migrating children under the age of 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Linear mixed models for longitudinal data
(2000) · Springer Series in Statistics · doi:10.1007/b98969 · Cited by 818
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608
Siegrist, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00342-6 · Cited by 346
Clark, A., & Sanderson, C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60317-2 · Cited by 343
Maternal Antibodies, Childhood Infections, and Autoimmune Diseases
Zinkernagel, R. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmra012493 · Cited by 299
Measles in Europe: an epidemiological assessment
Muscat, M., Bang, H., Wohlfahrt, J., Glismann, S., & Mølbak, K. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61849-8 · Cited by 219
Factors Determining Prevalence of Maternal Antibody to Measles Virus throughout Infancy: A Review
Caceres, V. M., Strebel, P. M., & Sutter, R. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313926 · Cited by 174
Leuridan, E., & Van Damme, P. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.020 · Cited by 160
Self-citationGans, H. A., DeHovitz, R., Forghani, B., Beeler, J., Maldonado, Y., & Arvin, A. M. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00341-4 · Cited by 135
Vaccination in the Neonatal Period and Early Infancy
Siegrist, C. (2000) · International Reviews of Immunology · doi:10.3109/08830180009088505 · Cited by 125
Scott, S., Cumberland, P., Shulman, C. E., Cousens, S., Cohen, B. J., Brown, D. W. G., Bulmer, J. N., Dorman, E. K., Kawuondo, K., Marsh, K., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429963 · Cited by 117
Effect of maternal antibodies on the infant immune response
Glezen, W. P. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00339-6 · Cited by 116
Gans, H. A., Yasukawa, L. L., Alderson, A., Rinki, M., DeHovitz, R., Beeler, J., Audet, S. A., Maldonado, Y., & Arvin, A. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/421032 · Cited by 114
Maternally derived measles immunity in era of vaccine-protected mothers
Lennon, J. L., & Black, F. L. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)81039-3 · Cited by 109
Progress in Global Measles Control and Mortality Reduction, 2000-2006
(2008) · JAMA · doi:10.1001/jama.299.4.400 · Cited by 109
Waning antibodies in measles and rubella vaccinees—a longitudinal study
Kremer, J. R., Schneider, F., & Muller, C. P. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.12.015 · Cited by 95
Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine
LeBaron, C. W., Forghani, B., Beck, C., Brown, C., Bi, D., Cossen, C. K., & Sullivan, B. J. (2008) · The Journal of Infectious Diseases · doi:10.1086/596207 · Cited by 93
Reduced measles immunity in infants in a well-vaccinated population
Pabst, H. F., Spady, D. W., MARUSYK, R. G., Carson, M. M., Chui, L., Joffres, M. R., & GRIMSRUD, K. M. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199207000-00004 · Cited by 90
Pebody, R. G., Gay, N. J., Hesketh, L. M., Vyse, A., Morgan-Capner, P., Brown, D., Litton, P. A., & Miller, E. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00435-2 · Cited by 85
Leineweber, B., Grote, V., Schaad, B., & Heininger, U. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00019 · Cited by 76
Timeliness of MMR vaccination?influence on vaccination coverage
Dannetun, E., Tegnell, A., Hermansson, G., Törner, A., & Giesecke, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.04.018 · Cited by 67
Klinge, J., Lugauer, S., Korn, K., Heininger, U., & STEHR, K. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00096-7 · Cited by 61
Brugha, R., Ramsay, M. E., Forsey, T., & Brown, D. (1996) · Epidemiology and Infection · doi:10.1017/s0950268800059203 · Cited by 60
Gagneur, A., Pinquier, D., Aubert, M., Balu, L., Brissaud, O., de Pontual, L., Guen, C. G., Hau-Rainsard, I., Mory, O., Picherot, G., et al. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00229-08 · Cited by 53
Long-term persistence of antibodies after one or two doses of MMR-vaccine
Vandermeulen, C., Roelants, M., Leroux-Roels, G. G., Damme, P. V., & Hoppenbrouwers, K. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.008 · Cited by 49
Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status
Linder, N., Tallen-Gozani, E., German, B., Duvdevani, P., Ferber, A., & Sirota, L. (2003) · Vaccine · doi:10.1016/j.vaccine.2003.10.009 · Cited by 41
Serres, G. D., Joly, J. R., Fauvel, M., Meyer, F., Mâsse, B. R., & Boulianne, N. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00283-6 · Cited by 35
Maternally derived measles immunity in children of naturally infected and vaccinated mothers
Jenks, P. J., Caul, E. O., & ROOME, A. P. C. H. (1988) · Epidemiology and Infection · doi:10.1017/s095026880005442x · Cited by 32
Cited by
Factors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
Moss, W. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31463-0 · Cited by 530
Moss, W. J., & Griffin, D. E. (2012) · The Lancet · doi:10.1016/s0140-6736(10)62352-5 · Cited by 337
Fu, C., Lu, L., Wu, H., Shaman, J., Cao, Y., Fang, F., Yang, Q., He, Q., Yang, Z., & Wang, M. (2016) · Scientific Reports · doi:10.1038/srep38874 · Cited by 71
Metadata
- Authors
- Leuridan, E., Hens, N., Hutse, V., Ieven, M., Aerts, M., & Van Damme, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-05-13
- Volume
- 340
- Issue
- may18 2
- Pages
- c1626-c1626
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2150138962
- Cited by
- 284
- References
- 29
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.